Facetten
Zugriff
Einrichtung
Medientyp
- Text 7
Karte
Erscheinungsjahr
Autor/in
- Blauvelt, Andrew
- Reich, Kristian
- Armstrong, April 2
- Bissonnette, Robert 2
- Foley, Peter 2
- alle zeigen
Sprache
- Englisch 7
7 Einträge gefunden
-
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
- Reich, Kristian
- Thyssen, Jacob P
- Blauvelt, Andrew
- Eyerich, Kilian
- Soong, Weily
- Rice, Zakiya P
- Hong, H Chih-Ho
-
Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab
- Mehta, Heena
- Mashiko, Shunya
- Angsana, Julianty
- Rubio, Manuel
- Hsieh, Ya-Ching M
- Maari, Catherine
- Reich, Kristian
-
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
- Gordon, Kenneth B
- Foley, Peter
- Krueger, James G
- Pinter, Andreas
- Reich, Kristian
- Vender, Ronald
- Vanvoorden, Veerle
-
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial
- Reich, Kristian
- Papp, Kim A
- Blauvelt, Andrew
- Langley, Richard G
- Armstrong, April
- Warren, Richard B
- Gordon, Kenneth B
-
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure
- Armstrong, April
- Paul, Carle
- Puig, Luis
- Boehncke, Wolf Henning
- Freeman, Michael
- Torii, Hideshi
- Papp, Kim
-
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study
- Deleuran, Mette
- Thaçi, Diamant
- Beck, Lisa A
- de Bruin-Weller, Marjolein
- Blauvelt, Andrew
- Forman, Seth
- Bissonnette, Robert
-